Breast Cancer News and Research

Latest Breast Cancer News and Research

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

NewLink Genetics Corporation, a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the initiation of a double-blind, randomized, placebo-controlled Phase 2 clinical study of its first IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, indoximod, in patients with metastatic breast cancer.

2 Apr 2013

Researchers examine benefits of surgical intervention in breast cancer patients with lung metastases

Patients with primary breast cancer that has spread to the lungs may live longer if the lung metastases are surgically removed, according to a study published in the April 2013 issue of The Annals of Thoracic Surgery.

1 Apr 2013

Looking good helps women cancer patients feel better, gives more confidence to cope with disease

A year ago, Colleen Williams was into the natural look. She seldom bothered to put on makeup and she let her long, wavy, brown hair flow free. Cancer treatment changed that. These days, when she feels well enough to go to work, Williams wears her "cute hat" to cover her newly-balding head and takes a little extra time in the morning to pencil in her thinning brows and apply concealer to make her skin look a little less gray.

30 Mar 2013

Study shows hormonal therapy increases risk of breast cancer

The study Dr. Chlebowski authored reported that estrogen plus progestin use is linked with increased breast cancer incidence. In addition, it said the prognosis is similar for both users and nonusers of combined hormone therapy, suggesting that mortality from breast cancer may be higher for hormone therapy users as well.

30 Mar 2013

Viewpoints: Budget woes leave Democrats with painful choices; David Kessler on health hazards of antibiotics in meat; the pros and cons of not hiring smokers

USA Today: Entitlements Or Investment? Democrats Must Pick Democrats therefore face a fundamental and inescapable choice: they can support funding current consumption, especially by older Americans who are not working, or future investment, particularly in scientific research and innovation.

29 Mar 2013

Researchers identify HNF1B gene that can increase risk of ovarian cancer

Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis of more than 16,000 women with ovarian cancer and more than 26,000 healthy women.

28 Mar 2013

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause.

28 Mar 2013

Study: New genetic variants may increase cancer risk

The European Collaborative Oncological Gen-Environmental Study (COGS) project, whose main goal is to decipher the complex genetic bases of breast, prostate and ovarian cancers, publishes today a total of 12 research articles in several prestigious journals, including Nature Genetics, Nature Communications, The American Journal of Human Genetics and PLOS Genetics.

28 Mar 2013

University of Maryland scientist selected as fellow of newly created AACR Academy

Angela H. Brodie, Ph.D., a University of Maryland scientist whose research paved the way for a new class of drugs widely used to treat breast cancer patients around the world, has been selected by the American Association for Cancer Research as a fellow of the newly created AACR Academy.

28 Mar 2013

Researcher discovers genetic variations that are linked to breast cancer

Working with an international consortium conducting research on breast, ovarian and prostate cancer among 200,000 people, Professor Jacques Simard, holder of the Canada Research Chair in Oncogenetics at Laval University, was actively involved in the discovery of DNA "spelling mistakes" linked to breast cancer.

28 Mar 2013

Cancer patients to get benefit from Elekta's Versa HD system at Hôpital Riviera's radiotherapy clinic

Cancer patients referred to Hôpital Riviera's (Vevey, Switzerland) new radiotherapy clinic will soon benefit from the center's acquisition of Elekta's advanced new linear accelerator, Versa HD.

From Elekta 27 Mar 2013

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

Triple negative breast cancer (TNBC) is a type of cancer that has none of the three markers that are currently used for targeted chemotherapy. These markers are estrogen receptor (ER), progesterone receptor (PR) and HER2.

27 Mar 2013

New analysis reveals online nutritional guidelines for cancer patients appear to be inconsistent

Radiation oncologists at Thomas Jefferson University Hospital are stressing the need for evidence-based, standardized guidelines on dietary recommendations for cancer patients—and with good reason.

27 Mar 2013

Study suggests possibility of engineering artificial ovaries in lab

A proof-of-concept study suggests the possibility of engineering artificial ovaries in the lab to provide a more natural option for hormone replacement therapy for women.

27 Mar 2013

Scientists discover novel compounds that can lead to new strategies for treating diseases

Using a broad spectrum of analytical tools, scientists from the Florida campus of The Scripps Research Institute have uncovered a class of novel compounds that can alter cell signaling activity, resulting in a variety of responses including a strong anti-inflammatory effect.

26 Mar 2013

Clinigen announces acquisition of Cardioxane from Novartis

Clinigen Group plc today announced the acquisition of Cardioxane (dexrazoxane) from Novartis for US$33 million in cash, payable in two tranches.

From Clinigen Group 26 Mar 2013

Experts to highlight the importance of research, prevention and treatment of cancer

April marks National Cancer Control Month, which focuses on the importance of prevention, treatment and research in the fight against cancer.

26 Mar 2013

Researchers devise a new technique to separate breast cancer cells from blood

About 1 in 4 deaths in the United States are due to cancer, but primary tumors are rarely fatal. Instead, it's when tumors metastasize that cancer becomes so deadly.

26 Mar 2013

Scientists develop new chemo drug that fights cancer without impacting fertility

A new gentler chemotherapy drug in the form of nanoparticles has been designed by Northwestern Medicine- scientists to be less toxic to a young woman's fertility but extra tough on cancer. This is the first cancer drug tested while in development for its effect on fertility using a novel in vitro test.

25 Mar 2013

Moderated discussion on progress toward learning health system

The American Society of Clinical Oncology and the Conquer Cancer Foundation invite you to a moderated discussion of progress toward a "learning health system" that will transform cancer care and speed the search for cures.

25 Mar 2013

Breast Cancer News and Research

Latest Breast Cancer News and Research

NewLink Genetics starts Phase 2 clinical study of indoximod in patients with metastatic breast cancer

Researchers examine benefits of surgical intervention in breast cancer patients with lung metastases

Looking good helps women cancer patients feel better, gives more confidence to cope with disease

Study shows hormonal therapy increases risk of breast cancer

Viewpoints: Budget woes leave Democrats with painful choices; David Kessler on health hazards of antibiotics in meat; the pros and cons of not hiring smokers

Researchers identify HNF1B gene that can increase risk of ovarian cancer

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

Study: New genetic variants may increase cancer risk

University of Maryland scientist selected as fellow of newly created AACR Academy

Researcher discovers genetic variations that are linked to breast cancer

Cancer patients to get benefit from Elekta's Versa HD system at Hôpital Riviera's radiotherapy clinic

Biological markers for triple-negative breast cancer (TNBC): an interview with Alexandre Templier, CEO of Quinten

New analysis reveals online nutritional guidelines for cancer patients appear to be inconsistent

Study suggests possibility of engineering artificial ovaries in lab

Scientists discover novel compounds that can lead to new strategies for treating diseases

Clinigen announces acquisition of Cardioxane from Novartis

Experts to highlight the importance of research, prevention and treatment of cancer

Researchers devise a new technique to separate breast cancer cells from blood

Scientists develop new chemo drug that fights cancer without impacting fertility

Moderated discussion on progress toward learning health system

Innovation in neuroscience drug discovery - eBook eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in